市場調査レポート
商品コード
1451764
牛ヘルスケア市場:製品タイプ、エンドユーザー、地域別、2024-2032Cattle Healthcare Market by Product Type (Vaccines, Pharmaceuticals, Feed additives), End User (Dairy farms, Veterinary hospitals, and Others), and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
牛ヘルスケア市場:製品タイプ、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2~3営業日
|
世界の牛ヘルスケア市場規模は2023年に88億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに122億米ドルに達し、2024年から2032年の間に3.62%の成長率(CAGR)を示すと予測しています。動物性タンパク質に対する需要の増大、可処分所得水準の拡大、人畜共通感染症の蔓延が市場を牽引する主な要因のひとつです。
牛ヘルスケアとは、牛の肉体的・精神的健康のあらゆる側面の管理を指します。家畜の幸福と生産性を維持するために、健康問題の予防、診断、治療を行う。牛ヘルスケアの主な目的は、病気の蔓延を防ぎ、最適な栄養と成長を確保し、安全で清潔な環境を提供し、効果的な疾病管理対策を実施することです。牛群の健康状態を定期的にモニタリング・評価することは、潜在的な健康問題を早期に発見し、治療するために不可欠です。効果的な牛ヘルスケアには、適切な管理方法、獣医学的ケア、薬の適切な使用の組み合わせが必要です。これには、ワクチン接種プログラム、寄生虫駆除、栄養管理、疾病サーベイランスプログラムなどが含まれます。さらに、適切な牛ヘルスケアを実施することで、動物の福祉を向上させ、生産性を高め、畜産業の持続可能性を促進することができます。
市場を牽引する主な要因の1つは、世界の人口増加による動物性タンパク質需要の増大です。また、大衆の可処分所得水準が拡大しているため、牛を含む家畜の生産が増加しており、市場の見通しは明るいです。このほか、牛結核、ブルセラ症、サルモネラ症などの人獣共通感染症の流行が増加しているため、動物の健康と疾病対策が重視されています。これに加えて、家畜生産者の間で、事業の持続可能性を確保するために動物の健康と福祉が重要であるという意識が高まっていることも、市場の成長にプラスの影響を与えています。これに伴い、特に新興経済圏における酪農産業の急激な成長が市場成長を後押ししています。これらの要因とは別に、家畜生産への投資の増加が、この産業を支える牛ヘルスケア製品とサービスの需要増につながっています。さらに、環境問題への関心の高まりから、持続可能な畜産を促進する牛用ヘルスケア製品やサービスへの注目が高まっています。さらに、世界各国の政府は、動物用医薬品の安全で倫理的な使用を保証するために、疾病監視プログラム、ワクチン接種キャンペーン、規制など、動物の健康と福祉を促進するためのイニシアチブを取っています。さらに、技術の著しい進歩により、ワクチン、検査、医薬品など、新しく革新的な牛ヘルスケア製品とサービスの開発が進んでおり、市場の見通しは明るいです。
The global cattle healthcare market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The augmenting demand for animal protein, expanding disposable income levels, and increasing prevalence of zoonotic diseases represent some of the key factors driving the market.
Cattle healthcare refers to the management of all aspects of the physical and mental health of cattle. It involves preventing, diagnosing, and treating health issues in order to maintain the well-being and productivity of the animals. The primary objectives of cattle healthcare include preventing the spread of diseases, ensuring optimal nutrition and growth, providing a safe and clean environment, and implementing effective disease control measures. Regular monitoring and evaluation of the herd's health are essential for the early detection and treatment of potential health issues. Effective cattle healthcare requires a combination of good management practices, veterinary care, and appropriate use of medications. This may include vaccination programs, parasite control, nutritional management, and disease surveillance programs. Moreover, implementing proper cattle healthcare practices can improve animal welfare, enhance productivity, and promote sustainability in the livestock industry.
One of the primary factors driving the market is the augmenting demand for animal protein due to the growing population globally. Additionally, on account of the expanding disposable income levels of the masses, there is a rise in the production of livestock, including cattle, thus creating a positive market outlook. Other than this, the increasing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, and salmonellosis, is creating a greater emphasis on animal health and disease control measures. Besides this, the rising awareness among livestock producers regarding the importance of animal health and welfare to ensure the sustainability of their operations is positively influencing market growth. In line with this, the exponential growth in the dairy industry, specifically in emerging economies, is propelling the market growth. Apart from these factors, the increasing investment in livestock production is leading to increased demand for cattle healthcare products and services to support the industry. Furthermore, the growing environmental concerns have led to an increasing focus on cattle healthcare products and services that promote sustainable livestock production. Moreover, governments across the world are taking initiatives to promote animal health and welfare, such as disease surveillance programs, vaccination campaigns, and regulations, to ensure the safe and ethical use of veterinary drugs. Furthermore, significant technological advancements are leading to the development of new and innovative cattle healthcare products and services, such as vaccines, tests, and medicines, thus creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each segment of the global cattle healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the product type and end user.
Vaccines
Pharmaceuticals
Analgesics
Anti-infective
Anti-inflammatory
Parasiticides
Others
Feed additives
Medicinal
Nutritional
The report has provided a detailed breakup and analysis of the cattle healthcare market based on the product type. This includes vaccines, pharmaceuticals (analgesics, anti-infectives, anti-inflammatory, parasiticides, and others), and feed additives (medicinal and nutritional).
Dairy farms
Veterinary hospitals
Others
A detailed breakup and analysis of the cattle healthcare market based on the end user has also been provided in the report. This includes dairy farms, veterinary hospitals, and others. According to the report, veterinary hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cattle healthcare. Some of the factors driving the North America cattle healthcare market included increasing demand for animal protein, technological advancements in veterinary medicine, and rising awareness of animal welfare.
The report has also provided a comprehensive analysis of the competitive landscape in the global cattle healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BioZyme Inc., Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG), Ceva Sante Animate, Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.